2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid

C14H25N5O6 — CID 134258063

IUPAC2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid
SMILESCC[C@H](C)C(NC(=O)NC(C(=O)O)C(C)O)c1nnc([C@@H](N)CO)o1
InChIInChI=1S/C14H25N5O6/c1-4-6(2)9(12-19-18-11(25-12)8(15)5-20)16-14(24)17-10(7(3)21)13(22)23/h6-10,20-21H,4-5,15H2,1-3H3,(H,22,23)(H2,16,17,24)/t6-,7?,8-,9?,10?/m0/s1
InChIKeyGGSAHEBFTHRJJO-XMVHQOEDSA-N
MW359.38 g/mol
LogP-0.72
Rot. Bonds9

About 2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid

2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid (PubChem CID 134258063) has the molecular formula C14H25N5O6 and a molecular weight of 359.38 g/mol. Its IUPAC name is 2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid.

Molecular Properties

Compound Name2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid
PubChem CID134258063
Molecular FormulaC14H25N5O6
Molecular Weight359.38 g/mol
Exact Mass359.18
IUPAC Name2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid
SMILESCC[C@H](C)C(NC(=O)NC(C(=O)O)C(C)O)c1nnc([C@@H](N)CO)o1
InChIInChI=1S/C14H25N5O6/c1-4-6(2)9(12-19-18-11(25-12)8(15)5-20)16-14(24)17-10(7(3)21)13(22)23/h6-10,20-21H,4-5,15H2,1-3H3,(H,22,23)(H2,16,17,24)/t6-,7?,8-,9?,10?/m0/s1
InChIKeyGGSAHEBFTHRJJO-XMVHQOEDSA-N
XLogP-0.72
TPSA183.83 Ų
H-Bond Donors6
H-Bond Acceptors8
Rotatable Bonds9
Heavy Atoms25
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500359.38
LogP ≤ 5-0.72
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 108

Analyze 2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid?
The IUPAC name of 2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid (CID 134258063) is 2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid.
What is the SMILES notation for 2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid?
The canonical SMILES for 2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid is CC[C@H](C)C(NC(=O)NC(C(=O)O)C(C)O)c1nnc([C@@H](N)CO)o1.
What is the InChIKey of 2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid?
The InChIKey is GGSAHEBFTHRJJO-XMVHQOEDSA-N. The full InChI is InChI=1S/C14H25N5O6/c1-4-6(2)9(12-19-18-11(25-12)8(15)5-20)16-14(24)17-10(7(3)21)13(22)23/h6-10,20-21H,4-5,15H2,1-3H3,(H,22,23)(H2,16,17,24)/t6-,7?,8-,9?,10?/m0/s1.
What are the key properties of 2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid?
2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid has a molecular weight of 359.38 g/mol, XLogP of -0.72, 9 rotatable bonds, 6 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[(2S)-1-[5-[(1S)-1-amino-2-hydroxyethyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]carbamoylamino]-3-hydroxybutanoic acid is sourced from PubChem (CID 134258063), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).